HIV in injecting drug users in Asian countries: Naltrexone implants are set to supersede harm minimisationBMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7483.147 (Published 13 January 2005) Cite this as: BMJ 2005;330:147
- Albert S Reece, general practitioner (firstname.lastname@example.org)
- Brisbane, QLD 4101, Australia
EDITOR—Wodak et al draw attention to intravenous drug use as a source of HIV transmission.1 They make the case for harm minimisation strongly but omit to mention that this is consistent with ongoing and even increasing drug use.2 Harm minimisation remains a hypothesis that has never been shown to fulfil Hill's …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial